Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety after 12 weeks oral administration of Imidafenacin 0.1mg
b.i.d versus Fesoterodine 4mg once daily for the urge incontinence and/or increased urinary
frequency associated with urgency as may occur in patients with overactive bladder.